These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 26330352)

  • 1. Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer.
    Aleskandarany MA; Sonbul SN; Mukherjee A; Rakha EA
    Pathobiology; 2015 Sep; 82(3-4):113-23. PubMed ID: 26330352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Complexity of Lymphovascular Invasion: The Role of Cell Migration in Breast Cancer as a Prototype.
    Kariri YA; Aleskandarany MA; Joseph C; Kurozumi S; Mohammed OJ; Toss MS; Green AR; Rakha EA
    Pathobiology; 2020; 87(4):218-231. PubMed ID: 32645698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A key genomic subtype associated with lymphovascular invasion in invasive breast cancer.
    Kurozumi S; Joseph C; Sonbul S; Alsaeed S; Kariri Y; Aljohani A; Raafat S; Alsaleem M; Ogden A; Johnston SJ; Aleskandarany MA; Fujii T; Shirabe K; Caldas C; Ashankyty I; Dalton L; Ellis IO; Desmedt C; Green AR; Mongan NP; Rakha EA
    Br J Cancer; 2019 Jun; 120(12):1129-1136. PubMed ID: 31114020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development.
    Aljohani AI; Toss MS; Green AR; Rakha EA
    Breast Cancer Res Treat; 2023 Apr; 198(3):423-435. PubMed ID: 36418517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study.
    Van den Eynden GG; Van der Auwera I; Van Laere SJ; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
    Br J Cancer; 2006 Jun; 94(11):1643-9. PubMed ID: 16670715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of genes and pathways related to lymphovascular invasion in breast cancer patients: A bioinformatics analysis of gene expression profiles.
    Klahan S; Wong HS; Tu SH; Chou WH; Zhang YF; Ho TF; Liu CY; Yih SY; Lu HF; Chen SC; Huang CC; Chang WC
    Tumour Biol; 2017 Jun; 39(6):1010428317705573. PubMed ID: 28651487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer.
    Aleskandarany MA; Sonbul S; Surridge R; Mukherjee A; Caldas C; Diez-Rodriguez M; Ashankyty I; Albrahim KI; Elmouna AM; Aneja R; Martin SG; Ellis IO; Green AR; Rakha EA
    Br J Cancer; 2017 Oct; 117(8):1176-1184. PubMed ID: 28829761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer.
    Gujam FJ; Going JJ; Edwards J; Mohammed ZM; McMillan DC
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):231-41. PubMed ID: 24075309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response.
    Asaoka M; Patnaik SK; Zhang F; Ishikawa T; Takabe K
    Breast Cancer Res Treat; 2020 Jun; 181(2):309-322. PubMed ID: 32285241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic concordance of reporting lymphovascular invasion in breast cancer.
    Rakha EA; Abbas A; Pinto Ahumada P; ElSayed ME; Colman D; Pinder SE; Ellis IO
    J Clin Pathol; 2018 Sep; 71(9):802-805. PubMed ID: 29599396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of Cyclin B2 (
    Aljohani AI; Toss MS; El-Sharawy KA; Mirza S; Ball GR; Green AR; Rakha EA
    Am J Cancer Res; 2022; 12(2):469-489. PubMed ID: 35261781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer.
    Aljohani AI; Toss MS; Kurozumi S; Joseph C; Aleskandarany MA; Miligy IM; Ansari RE; Mongan NP; Ellis IO; Green AR; Rakha EA
    Breast Cancer Res Treat; 2020 Jan; 179(1):79-90. PubMed ID: 31599393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of high mobility group protein 3 (
    Aljohani AI; Alsaeed SA; Toss MS; Raafat SA; Green AR; Rakha EA
    Am J Cancer Res; 2023; 13(11):5334-5351. PubMed ID: 38058796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-tumoural lipid composition and lymphovascular invasion in breast cancer via non-invasive magnetic resonance spectroscopy.
    Cheung SM; Husain E; Mallikourti V; Masannat Y; Heys S; He J
    Eur Radiol; 2021 Jun; 31(6):3703-3711. PubMed ID: 33270144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion.
    Sonbul SN; Aleskandarany MA; Kurozumi S; Joseph C; Toss MS; Diez-Rodriguez M; Nolan CC; Mukherjee A; Martin S; Caldas C; Ellis IO; Green AR; Rakha EA
    Mod Pathol; 2018 Nov; 31(11):1675-1682. PubMed ID: 29955149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between lymphovascular invasion and molecular subtypes in invasive breast cancer.
    Morkavuk ŞB; Güner M; Çulcu S; Eroğlu A; Bayar S; Ünal AE
    Int J Clin Pract; 2021 Apr; 75(4):e13897. PubMed ID: 33280209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological Evaluation of the Potential Anatomic Pathways of Systemic Metastasis from Primary Breast Cancer Suggests an Orderly Spread Through the Regional Lymph Nodes.
    David Nathanson S; Leonard-Murali S; Burmeister C; Susick L; Baker P
    Ann Surg Oncol; 2020 Nov; 27(12):4810-4818. PubMed ID: 32720039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer.
    Kariri YA; Alsaleem M; Joseph C; Alsaeed S; Aljohani A; Shiino S; Mohammed OJ; Toss MS; Green AR; Rakha EA
    Breast Cancer Res Treat; 2021 Jan; 185(2):293-305. PubMed ID: 33073304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calpastatin is associated with lymphovascular invasion in breast cancer.
    Storr SJ; Mohammed RA; Woolston CM; Green AR; Parr T; Spiteri I; Caldas C; Ball GR; Ellis IO; Martin SG
    Breast; 2011 Oct; 20(5):413-8. PubMed ID: 21531560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative tumour size as a predictor of the presence of lymphovascular invasion in lung adenocarcinoma.
    Grbić K; Mehić B; Udovičić-Gagula D; Valjevac A; Ćemerlić A; Krupić F
    Med Glas (Zenica); 2020 Aug; 17(2):363-368. PubMed ID: 32662606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.